ARTICLE | Emerging Company Profile
Infinity: Interrogating biology
June 24, 2002 7:00 AM UTC
Infinity Pharmaceuticals Inc. is going about drug discovery by taking a road between the path of classical natural products chemistry and shotgun combinatorial chemistry.
Infinity's technology has its origins at Harvard University, where Stuart Schreiber and Mike Foley were developing the use of high throughput chemistry to interrogate biology. Their approach to chemistry was the converse of the retro-synthetic method used by chemists over the last 40 years. ...